Dow, S&P 500, Nasdaq Futures Climb On Tech Earnings Optimism: AKAN, AAPL, RDDT, RIVN Stocks In Focus

Futures are up, but the signal is narrow

Stocktwits reported Dow Jones futures up 0.18%, S&P 500 futures up 0.20%, and Nasdaq 100 futures up 0.11% as of 8:57 p.m. ET. SPY, QQQ and DIA also rose in after-hours trading, while retail sentiment on Stocktwits for all three sat in “bullish” territory.

That is a sentiment print, not a valuation argument.

The prior cash session had already priced in a large amount of optimism. The S&P 500 and Nasdaq Composite closed at record highs, up 1.02% and 0.89%, respectively. The Dow added about 790 points, or 1.62%. Stocktwits also noted that U.S. markets recorded their best month since 2020, helped by technology gains and enthusiasm around artificial intelligence stocks.

The accounting question is simple: are earnings revisions rising faster than multiples? If not, the market is just paying more for the same dollar of future profit. That can work for a while. It is not durable evidence.

Apple and Reddit are earnings stories; Akanda and Rivian are not the same trade

Apple rose about 2% in overnight trading after reporting second-quarter revenue and earnings above Wall Street expectations. Stocktwits also said Apple gave third-quarter guidance well ahead of consensus estimates. For Apple, investors should watch the spread between revenue growth, gross margin, and cash conversion. A clean earnings beat matters only if it turns into cash and not just accrual comfort.

Reddit moved more sharply. Its shares rose more than 12% in extended trading after first-quarter results beat Street expectations. The company also gave stronger forward guidance, with Stocktwits pointing to increased advertising demand from a growing user base. That is the relevant test: whether user growth is converting into advertising yield without forcing a matching rise in operating costs.

Akanda is a different file. The cannabis company gained more than 88% on Thursday and rose more than 40% overnight, according to Stocktwits, on optimism around potential marijuana reclassification from Schedule I to Schedule III. That is a policy-expectation move, not an earnings-quality move. Investors should separate balance-sheet survivability from regulatory optionality. The stock can move before the financial statements improve.

Rivian fell more than 4% overnight after failing to provide enough fresh detail on its new R2 electric SUV. That reaction is also rationally different. For an EV maker, product narrative does not replace unit economics. The questions remain production cost, capital intensity, gross margin path and cash burn. None of those can be solved by a model name.

What to check before treating this as a broad market confirmation

The broader backdrop remains crowded. MSN’s headline points to AI spending, earnings hopes and the Federal Reserve outlook as likely drivers for U.S. stocks in the second half. Japan Today separately framed Tokyo’s rally as AI-led and earnings-season focused. Insider Monkey flagged JPMorgan ahead of earnings season. The common thread is obvious: markets are now leaning on earnings season to validate valuations already expanded by AI and rate expectations.

That creates a practical checklist.

First, compare after-hours price moves with the actual change in forward guidance. A 2% move on Apple after stronger guidance is not the same risk as a 40% move in Akanda on regulatory optimism.

Second, inspect cash quality. Revenue beats are less useful when receivables rise faster than sales or when margins are supported by cost timing. The income statement can flatter. Cash flow is harder to stage.

Third, avoid treating index futures as proof of breadth. The overnight gains were modest, while the single-stock dispersion was large. That is a market rewarding specific narratives, not necessarily a market re-rating every sector on improved fundamentals.

For now, the intrinsic-value conclusion is restrained: the earnings tape is constructive for selected technology names, but the index move does not by itself justify a higher market multiple. The burden shifts to reported cash flow, guidance quality and whether AI-linked spending turns into operating profit rather than capitalized hope.